Resurrecting an Abandoned Drug Wednesday, March 30, 2016 Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses. Bristol-Myers Squibb to Acquire Padlock Therapeutics Thursday, March 24, 2016 Expands BMS immunoscience pipeline with potentially transformational approach to treating rheumatoid arthritis and other autoimmune diseases.Deleting HIV from Human T-Cells Wednesday, March 23, 2016 Building on their groundbreaking research, Temple University scientists make another breakthrough in a potential cure for HIV.Antibiotics for Appendicitis Tuesday, March 22, 2016 Using antibiotics as the primary treatment for mild appendicitis does not increase the risk for complications at least in the first year. Marijuana Based Drug Posts Positive Results Monday, March 21, 2016 GW Pharmaceuticals announces the positive results of the first pivotal Phase 3 study of its investigational medicine Epidiolex® (cannabidiol or CBD) for the treatment of Dravet syndrome. Common Painkillers Are More Dangerous Than We Think Monday, March 21, 2016 Commonly prescribed NSAIDs could be causing untold damage to patients. Possible Drug for Listeria Monday, March 21, 2016 Chemical compounds discovered which are able to attenuate the virulence of the bacterial human pathogen Listeria monocytogenes. Rapidly Killing Bacteria Monday, March 21, 2016 Light-activated gold nanoparticles destroy potentially deadly bacterial cells in seconds.Sanofi, DiCE Molecules Collaborate Friday, March 18, 2016 Five-year collaboration encompasses up to 12 targets and provides up to $184 million in milestone payments per target.